Pew Latin American Fellow Wins Grant to Study Dengue Virus

Diego Alvarez, a 2009 Pew Latin American fellow and associate investigator at the National University of San Martin in Argentina, has received support from the Bunge and Born Foundation to develop diagnostic techniques for the virus that causes dengue fever.

Dengue virus affects up to 100 million people every year and is prone to pandemics, especially in poor urban areas, including parts of Latin America. It is transmitted through mosquito bites and produces symptoms such as fever, pain, and rash—and a potentially lethal complication known as severe dengue or dengue hemorrhagic fever.

Early diagnosis of dengue infections is crucial to increasing survival rates, according to the World Health Organization. The Bunge and Born funding will enable Alvarez to create a biochemical test to detect dengue molecules using immune cells.

As a Pew Latin American fellow, Alvarez trained in the laboratory of Hervé Agaisse at the Yale School of Medicine. Their studies focused on understanding how viruses spread from cell to cell within the body.

Learn more about Pew’s biomedical programs.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.